Safety and Efficacy Assessments of Osalmid in Multiple Myeloma
Status:
Active, not recruiting
Trial end date:
2021-05-18
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety and efficacy of a traditional cholagogue drug osalmid,
2-hydroxy-N-(4-hydroxyphenyl)-benzamide, in the treatment of multiple myeloma (MM).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai 10th People's Hospital
Collaborator:
Shanghai Institute of Materia Medica, Chinese Academy of Sciences